These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 8529315

  • 1. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T, Magari Y, Kamberi P, Ishii T, Tomo T, Yasumori R, Nasu M.
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [Abstract] [Full Text] [Related]

  • 2. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T, Magari Y, Mizunaga S, Okabe E, Sumie A, Ishii T, Tomo T, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
    [Abstract] [Full Text] [Related]

  • 3. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T, Sumie A, Ishii T, Tomo T, Magari Y, Sato J, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [Abstract] [Full Text] [Related]

  • 4. [Urinary cross-linked FDP in various renal diseases].
    Inuma H.
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K, Ito Y, Uriu K, Eto S.
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [Abstract] [Full Text] [Related]

  • 6. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
    Shibata T, Magari Y, Perparim K, Sumie A, Ishii T, Tomo T, Sato J, Yasumori R, Nasu M.
    Nephron; 1995 Jan; 69(1):54-8. PubMed ID: 7891798
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K, Yasumuro Y, Taki M, Suzuki N, Tanabe H, Ichikawa Y.
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [Abstract] [Full Text] [Related]

  • 8. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
    Kaizu K, Ito Y, Uriu K, Komine N, Hashimoto O, Eto S.
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
    [Abstract] [Full Text] [Related]

  • 9. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL, Francis CW, Knutson DW, Marder VJ.
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [Abstract] [Full Text] [Related]

  • 10. [Study on cases of D dimer values were dissociated from FDP-E].
    Himizu M, Ishii K, Katagiri H, Saga K, Ono F, Yamamoto M, Todoroki T, Kawai Y, Watanabe K, Iri H.
    Rinsho Byori; 1991 Mar; 39(3):302-8. PubMed ID: 2051606
    [Abstract] [Full Text] [Related]

  • 11. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN, Kozlovskaia LV, Rameeva AS, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2007 Mar; 79(6):10-5. PubMed ID: 17684960
    [Abstract] [Full Text] [Related]

  • 12. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
    Wróbel T, Poreba M, Mazur G, Poreba R, Pyszel A, Beck B, Steinmetz-Beck A, Andrzejak R, Kuliczkowski K.
    Neoplasma; 2006 Mar; 53(3):253-8. PubMed ID: 16652197
    [Abstract] [Full Text] [Related]

  • 13. Plasma D dimer: a useful marker of fibrin breakdown in renal failure.
    Gordge MP, Faint RW, Rylance PB, Ireland H, Lane DA, Neild GH.
    Thromb Haemost; 1989 Jun 30; 61(3):522-5. PubMed ID: 2799764
    [Abstract] [Full Text] [Related]

  • 14. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K, Dohi K, Fujii Y, Ishikawa H.
    Nihon Jinzo Gakkai Shi; 1991 Aug 30; 33(8):719-29. PubMed ID: 1770632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Persistent discrepancy between FDP and D-dimer in a patient with acute leukemia].
    Sato N, Takahashi H, Nikuni K, Seki Y, Wada K, Tatewaki W, Shibata A.
    Rinsho Ketsueki; 1995 Mar 30; 36(3):212-7. PubMed ID: 7783324
    [Abstract] [Full Text] [Related]

  • 19. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K, Matsunaga T, Kawahara S, Sakamoto S, Kamitsuji H.
    Thromb Res; 1989 Feb 15; 53(4):367-77. PubMed ID: 2929008
    [Abstract] [Full Text] [Related]

  • 20. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA, Dempfle CE, Matsuda M, Heene DL.
    Thromb Haemost; 1997 Sep 15; 78(3):1069-78. PubMed ID: 9308756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.